AMPH — Amphastar Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapContrarian

Annual balance sheet for Amphastar Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	106	137	176	257	222
Net Total Accounts Receivable
Net Total Receivables	66.4	78.9	89	115	138
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	280	318	378	490	534
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	281	271	265	316	345
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	631	672	742	1,513	1,577
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	112	104	94.9	225	174
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	229	226	213	873	845
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	402	446	529	639	732
Total Liabilities & Shareholders' Equity	631	672	742	1,513	1,577
Total Common Shares Outstanding